MicroGenDX
Rick Martin has a diverse work experience spanning over several decades. Rick began their career at Pfizer in 1989, holding various roles such as Senior Sales Director and Senior Director Sales Europe/Canada. During this time, they focused on increasing sales force effectiveness and improving performance across different markets. In 1997, they moved to Pfizer Turkey as a Business Unit Manager, where they were responsible for marketing and sales for a large business unit. In 2008, they joined Advanced BioHealing, Inc. as an Account Manager. In 2012, they became the Chief Executive Officer at Apollo Healing Technologies and served in this role until 2016. Currently, they are the CEO of MicroGenDX, a position they have held since 2016.
Rick Martin earned a Bachelor of Arts (BA) degree from the University of Massachusetts Amherst. The specific years of their education are not provided.
This person is not in any teams
MicroGenDX
MicroGenDX provides qPCR+NGS sequencing for the detection of infectious diseases. The American Medical Association (AMA) and Medicare have issued a billing code to MicroGenDX to provide this testing service, recognizing this technology as medically necessary. MicroGenDX is trusted by over 39,000 physicians worldwide and has helped over 900,000 patients with diagnostic testing for their chronic and life-threatening infections. MicroGenDX is a College of American Pathologists (CAP) accredited and Clinical Laboratory Improvements Amendments (CLIA) licensed clinical laboratory. Tens of thousands of patients with chronic and often life-threatening infections have benefited from MicroGenDX’s work. MicroGenDX's NGS technology offers several advantages over traditional culture-based methods for identifying microorganisms. It can detect a wider range of microorganisms, including those that are difficult to culture or grow in a laboratory. It also provides more accurate and comprehensive results, as it can detect multiple microorganisms in a single sample and identify them at the species or strain level. Additionally, NGS technology is faster than traditional methods, allowing for quicker diagnosis and treatment decisions. MicroGenDX's testing services are used in a variety of settings, including hospitals, long-term care facilities, dental offices, and veterinary clinics. Their technology has been applied to a wide range of clinical conditions, including chronic wounds, orthopedic infections, respiratory infections, and urinary tract infections, among others.